Effects of Long-Term Treatment with Ranirestat, a Potent Aldose Reductase Inhibitor, on Diabetic Cataract and Neuropathy in Spontaneously Diabetic Torii Rats

<table>Immunostaining for CML (original magnification 4x) at 40 weeks. Immunostaining for CML shows severe staining in an untreated eye (top) compared with minimal staining in a ranirestat-treated eye (bottom).</table>

Journal of Diabetes Research

fig16

Figure 16

Figure 16: Effects of Long-Term Treatment with Ranirestat, a Potent Aldose Reductase Inhibitor, on Diabetic Cataract and Neuropathy in Spontaneously Diabetic Torii Rats 

Figure 16 | Effects of Long-Term Treatment with Ranirestat, a Potent Aldose Reductase Inhibitor, on Diabetic Cataract and Neuropathy in Spontaneously Diabetic Torii Rats 